Advertisement

Ads Placeholder
Loading...

BioMarin Pharmaceutical Inc.

BMRN•NASDAQ
Healthcare
Biotechnology
$55.50
$-1.74(-3.04%)
U.S. Market opens in 25h 23m

BioMarin Pharmaceutical Inc. (BMRN) Stock Overview

Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap10.7B
P/E Ratio30.51
EPS (TTM)$1.80
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$50.91
3 Months$59.58
1 Year Target$39.73

BMRN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMarin Pharmaceutical Inc. (BMRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.51 and a market capitalization of 10.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.04%
5-Day Change
-0.09%
1-Month Change
-5.18%
3-Month Change
-6.64%
6-Month Change
0.13%
Year-to-Date (YTD) Change
-6.64%
1-Year Change
-17.75%
3-Year Change
-42.55%
5-Year Change
-29.14%
All-Time (Max) Change
322.70%

Contact Information

https://www.biomarin.com
415 506 6700
770 Lindaro Street, San Rafael, CA, 94901

Company Facts

30,400 Employees
IPO DateJul 26, 1999
CountryUS
Actively Trading

Frequently Asked Questions